Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Oxaliplatin-induced Peripheral Neuropathy
NCT05254639Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Donepezil with Placebo (2 arms). Primary endpoint: Quality of Life Questionnaire-Chemotherapy Induced Peripheral Neuropathy 20 at 4 months. Started Jun 2022; status: completed.
02
Drugs
donepezil
Beyond the preview
Go deeper on NCT05254639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05254639.